Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11857)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27 [PMID: 30984347 DOI: 10.4251/wjgo.v11.i1.17] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i1/17.htm |
| Number | Citing Articles |
| 1 |
Xiao-Dong Zhu, Li-Xiang Zhang, Pan-Quan Luo, Hai Zhu, Zhi-Jian Wei, A-Man Xu. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12191 doi: 10.1007/s00432-023-05131-0
|
| 2 |
Fangyuan Zhang, Menglan Zhai, Jinru Yang, Lei Zhao, Zhenyu Lin, Jing Wang, Tao Zhang, Dandan Yu. ‘FLARE’ of tumor marker in advanced gastric cancer treated with first-line systemic therapy. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221124029
|
| 3 |
Jun-Peng Lin, Jian-Xian Lin, Yu-Bin Ma, Jian-Wei Xie, Su Yan, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Xin-Fu Ma, Long-Long Cao, Mi Lin, Ru-Hong Tu, Chao-Hui Zheng, Ping Li, Chang-Ming Huang. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer. British Journal of Cancer 2020; 123(3): 418 doi: 10.1038/s41416-020-0901-z
|
| 4 |
Chang-Yue Zheng, Ju Wu, Chun-Sen Chen, Ze-Ning Huang, Yi-Hui Tang, Wen-Wu Qiu, Qi-Chen He, Guo-Sheng Lin, Qi-Yue Chen, Jun Lu, Jia-Bin Wang, Jian-Xian Lin, Long-Long Cao, Mi Lin, Ru-Hong Tu, Jian-Wei Xie, Ping Li, Chang-Ming Huang, Yu-Hui Zheng, Chao-Hui Zheng. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study. European Journal of Surgical Oncology 2023; 49(11): 107094 doi: 10.1016/j.ejso.2023.107094
|
| 5 |
Li-Li Shen, Hua-Long Zheng, Fang-Hui Ding, Jun Lu, Qi-Yue Chen, Bin-bin Xu, Zheng Xue, Jia Lin, Chang-Ming Huang, Chao-Hui Zheng. Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer. La radiologia medica 2023; 128(4): 402 doi: 10.1007/s11547-023-01617-6
|
| 6 |
Chikashi Shibata, Toru Nakano, Akihiro Yasumoto, Atsushi Mitamura, Kentaro Sawada, Hitoshi Ogawa, Tomoya Miura, Ichiro Ise, Kazuhiro Takami, Kuniharu Yamamoto, Yu Katayose. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01667-z
|
| 7 |
Xi Yin Yang, Kaifeng Zhu, Qiang Hu. The order of surgery and chemotherapy matters: Multimodality therapy and stage‐specific differences in survival in gastric cancer. Journal of Surgical Oncology 2023; 127(3): 517 doi: 10.1002/jso.27158
|
| 8 |
Shusuke Yagi, Koshi Kumagai, Souya Nunobe, Naoki Ishizuka, Toshifumi Yamaguchi, Yoshiro Imai, Masahiro Tsuda, Shusuke Haruta, Hiroki Fukunaga, Takanobu Yamada, Masahiro Goto. Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study. Japanese Journal of Clinical Oncology 2024; 54(4): 403 doi: 10.1093/jjco/hyad189
|
| 9 |
Fengcai Yan, Feng Shi, Xinbao Li, Hong Chang, Mulan Jin, Yan Li. Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin. Journal of International Medical Research 2021; 49(6) doi: 10.1177/03000605211022297
|
| 10 |
Murat Güner, Tayfun Kaya, Cengiz Aydın. Does CA 125 Predict Peritoneal Dissemination in Patients with Gastric Cancer?. Indian Journal of Surgery 2022; 84(4): 779 doi: 10.1007/s12262-021-03105-5
|
| 11 |
Weiqiang You, Zerong Cai, Nengquan Sheng, Li Yan, Huihui Wan, Yongkun Wang, Jian Ouyang, Lu Xie, Xiaojian Wu, Zhigang Wang. Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.848783
|
| 12 |
Vishnu Gopal, Yadav Nisha, Prasanth Ganesan, Smita Kayal, Zachariah Bobby, Subathra Adithan, Prasanth Penumadu, Vishnu P. Ramakrishnalay, Bhanu P. Bandlamudi, Arnab Bahttacharjee, Sindhu Dahagama, Biswajit Dubashi. Role of CYFRA 21-1 and CEA as prognostic and predictive markers in locally advanced and metastatic gastric carcinoma. Journal of Cancer Research and Therapeutics 2024; 20(5): 1412 doi: 10.4103/jcrt.jcrt_746_22
|
| 13 |
Yilin Tong, Yan Zhao, Zexing Shan, Jianjun Zhang. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07666-8
|
| 14 |
Elisa Boldrin, Marcodomenico Mazza, Maria Assunta Piano, Rita Alfieri, Isabella Monia Montagner, Giovanna Magni, Maria Chiara Scaini, Loretta Vassallo, Antonio Rosato, Pierluigi Pilati, Antonio Scapinello, Matteo Curtarello. Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients. Cancers 2022; 14(9): 2180 doi: 10.3390/cancers14092180
|
| 15 |
Ai-Hua Sun, Xin-Yu Zhang, Yang-Yang Huang, Lei Chen, Qing Wang, Xiao-Cong Jiang. Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients. World Journal of Clinical Oncology 2024; 15(8): 1033-1047 doi: 10.5306/wjco.v15.i8.1033
|
| 16 |
Jin Moriyama, Yoko Oshima, Tatsuki Nanami, Takashi Suzuki, Satoshi Yajima, Fumiaki Shiratori, Kimihiko Funahashi, Hideaki Shimada. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. Surgery Today 2021; 51(10): 1638 doi: 10.1007/s00595-021-02248-y
|
| 17 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World Journal of Gastrointestinal Surgery 2020; 12(12): 468-490 doi: 10.4240/wjgs.v12.i12.468
|
| 18 |
Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, Kazushi Miyata, Kazuhiro Furukawa, Osamu Maeda, Dai Shimizu, Shizuki Sugita, Naomi Kakushima, Satoshi Furune, Hiroki Kawashima, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers 2023; 15(21): 5197 doi: 10.3390/cancers15215197
|
| 19 |
Shun Zhang, Jing-Ze Li, Tao Du, Hai-Qiang Li, Ren-Hao Hu, Chi-Ye Ma, Xi-Mao Cui, Chun Song, Xiao-Hua Jiang, Antonio Giovanni Solimando. The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/3953004
|